KOMQUOVA
Live / Allowed — Publication / registration review complete (as of 02 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99524935
- Mark type
- Stylized text
- Filed
- 02 Dec 2025
- Published for opposition
- 21 Apr 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 26 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 11 Feb 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 11 Feb 2026 — LETTER OF SUSPENSION E-MAILED
- 11 Feb 2026 — SUSPENSION LETTER WRITTEN
- 10 Feb 2026 — ASSIGNED TO EXAMINER
- 02 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 02 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Dec 2025 — NEW APPLICATION ENTERED